Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DISCO: DIScontinuation of COncomitant Disease Modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors - a Randomized Long-term Non-inferiority Strategy Trial

NCT07802678 is registered in ClinicalTrials.gov with Sint Maartenskliniek as lead sponsor.

NCT NCT07802678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DISCO: DIScontinuation of COncomitant Disease Modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors - a Randomized Long-term Non-inferiority Strategy Trial
Lead sponsor
Sint Maartenskliniek
Phase
Phase 4
Overall status
Recruiting
Start date
July 14, 2026
Completion date
May 1, 2029
Enrollment
202 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)